Ascelia Pharma AB (publ) (STO:ACE)

Ascelia Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72.28	75.26	21.86	149.56	261.6	184.69
Cash & Short-Term Investments	72.28	75.26	21.86	149.56	261.6	184.69
Cash Growth	-24.49%	244.34%	-85.39%	-42.83%	41.64%	0.25%
Other Receivables	3.11	6.1	2.99	5.16	5.87	2.83
Receivables	3.11	6.1	2.99	5.16	5.87	2.83
Prepaid Expenses	1.04	0.61	0.66	0.79	0.96	0.53
Other Current Assets	1.76	1.75	3.43	5.36	6.18	8.28
Total Current Assets	78.18	83.72	28.94	160.87	274.61	196.32
Property, Plant & Equipment	1.16	0.12	1.06	0.63	1.82	1.99
Other Intangible Assets	57.07	57.08	57.07	57.07	57.06	57.06
Other Long-Term Assets	-0	-	-0	0	-	-
Total Assets	136.42	140.92	87.07	218.57	333.49	255.37
Accounts Payable	7.25	4.73	1.53	15.88	6.15	3.88
Accrued Expenses	12.62	12.73	8.52	19.66	16.34	12.98
Short-Term Debt	-	25.23	-	-	-	-
Current Portion of Leases	0.89	0.17	0.88	0.29	1.1	0.82
Current Income Taxes Payable	-	-	-	-	0.01	-
Other Current Liabilities	0.97	19.11	1.64	1.69	1.51	0.67
Total Current Liabilities	21.73	61.98	12.57	37.52	25.11	18.36
Long-Term Leases	0.29	-	0.18	0.19	0.55	0.96
Other Long-Term Liabilities	-0	-	-	-0	-	-
Total Liabilities	22.01	61.98	12.74	37.71	25.66	19.32
Common Stock	127.9	97.19	34.87	34.87	34.58	28.7
Additional Paid-In Capital	771.37	721.75	678.75	678.75	678.83	493.73
Retained Earnings	-785.93	-740.97	-639.96	-533.73	-405.83	-286.49
Comprehensive Income & Other	1.06	0.97	0.67	0.97	0.25	0.12
Shareholders' Equity	114.4	78.94	74.33	180.86	307.83	236.06
Total Liabilities & Equity	136.42	140.92	87.07	218.57	333.49	255.37
Total Debt	1.18	25.4	1.06	0.48	1.66	1.78
Net Cash (Debt)	71.1	49.86	20.8	149.07	259.94	182.91
Net Cash Growth	2.89%	139.76%	-86.05%	-42.65%	42.12%	-0.60%
Net Cash Per Share	0.67	0.92	0.62	4.28	7.89	6.96
Filing Date Shares Outstanding	117.47	96.11	33.76	33.67	33.67	28.19
Total Common Shares Outstanding	117.47	96.11	33.76	33.67	33.67	28.19
Working Capital	56.45	21.74	16.37	123.35	249.51	177.96
Book Value Per Share	0.97	0.82	2.20	5.37	9.14	8.37
Tangible Book Value	57.33	21.87	17.25	123.79	250.77	179
Tangible Book Value Per Share	0.49	0.23	0.51	3.68	7.45	6.35
Machinery	-	0.6	0.6	0.6	0.6	0.56

Source: S&P Global Market Intelligence. Standard template. Financial Sources.